Copyright
©The Author(s) 2022.
World J Orthop. Jan 18, 2022; 13(1): 11-35
Published online Jan 18, 2022. doi: 10.5312/wjo.v13.i1.11
Published online Jan 18, 2022. doi: 10.5312/wjo.v13.i1.11
Medication | Minimum time between last dose of medication and neuraxial injection or catheter placement | Minimum time after nerve/neuraxial cathether placement and administration of drug | Minimum time between last dose of drug and cathether removal | Minimum time between neuraxial injection or cathether removal and administration of drug |
Anticoagulants for venous thromboembolism prophylaxis | ||||
Enoxaparin (Lovenox); prophylaxis, once daily | 12 h | ≥ 12 h | ≥ 12 h | 4 h |
Enoxaparin (Lovenox); prophylaxis, b.i.d. | 12 h | Contraindicated while catheter in place | 4 h | |
Heparin SQ; prophylaxis; low-dose, b.i.d. and t.i.d. | 4-6 h | Immediately | 4-6 h | Immediately |
Heparin SQ; prophylaxis; higher-dose, b.i.d. and t.i.d. | 12 h and assessment of coagulation status | Safety of indwelling catheters has not been established for doses > 5000 Units SQ or total daily dose > 15000 Units SQ. Risk/benefit assessment required | Immediately | |
Dalteparin (Fragmin); prophylaxis, once daily | 12 h | ≥ 12 h | 12 h | 4 h |
Anticoagulants at therapeutic doses | ||||
Heparin IV; full Dose | 4-6 h and normal coagulation status | 1 h, with close monitoring | 4-6 h and normal coagulation status | 1 h |
Heparin SQ; therapeutic dose | 24 h and assessment of coagulation status | Contraindicated while catheter in place | Immediately | |
Enoxaparin (Lovenox); therapeutic dose | 24 h, consider checking anti-factor Xa level | Contraindicated while catheter in place | 4 h | |
Apixaban (Eliquis) | 72 h | Contraindicated while catheter in place | 6 h | |
Rivaroxaban (Xarelto) | 72 h | Contraindicated while catheter in place | 6 h | |
Warfarin (Coumadin) | 5 d and normal INR | Variable instructions regarding management of catheter | Immediately | |
Anti-platelet medications | ||||
NSAID’s | No restrictions, may increase risk of bleeding | |||
Aspirin | No restrictions, may increase risk of bleeding | |||
Plavix | 5-7 d | 24 h postoperatively; catheter may be maintained for 1-2 d due to delayed antiplatelet effect | Immediately if no loading dose given | |
Ticlodipine (Ticlid) | 10 days | 24 h postoperatively; catheter may be maintained for 1-2 d due to delayed antiplatelet effect | Immediately if no loading dose given | |
Ticagrelor (Brillinta) | 5-7 d | Contraindicated while catheter in place | Immediately if no loading dose given |
- Citation: Kamel I, Ahmed MF, Sethi A. Regional anesthesia for orthopedic procedures: What orthopedic surgeons need to know. World J Orthop 2022; 13(1): 11-35
- URL: https://www.wjgnet.com/2218-5836/full/v13/i1/11.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i1.11